Alnylam Pharmaceuticals develops novel therapeuticsbased RNAi and provides overviews of recent drug development programs
                          Made For
                          
                      
                  Alnylam Pharmaceuticals develops novel therapeuticsbased RNAi and provides overviews of recent drug development programs
Ashpool has identified 1 product used by Alnylam Pharmaceuticals
Ashpool has identified the primary mail recipient on this domain as Mimecast
| Format | Success Rate | 
| flast@alnylam.com |  | 
| last@alnylam.com |  | 
| firstlast@alnylam.com |  | 
| firstl@alnylam.com |  | 
| first@alnylam.com |  |